PAR-21-098 - Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
NOT-OD-22-179 |
ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
Jul 14, 2022 |
May 8, 2025
|
R21, R01, R61/R33, UG3/UH3, R34, U01 |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
NOT-OD-22-178 |
ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
Jul 14, 2022 |
May 8, 2025
|
R21, R01, UG3/UH3, R61/R33, R34, R03 |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
NOT-OD-22-106 |
ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
May 12, 2022 |
May 8, 2025
|
R03, R01, R34, R21, UG3/UH3, R61/R33, 333 |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
NOT-OD-22-107 |
ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
May 12, 2022 |
May 8, 2025
|
333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
|